J&J unit gets approval in Canada for glucose-management system

07/16/2009 | American City Business Journals

Animas, a Johnson & Johnson subsidiary, received approval from Health Canada to sell its OneTouch Ping glucose-management system. The device, which was approved by the FDA in 2008, allows diabetic patients to measure insulin doses and wirelessly alert the insulin pump to release insulin.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
Catheter Engineer Manager
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Senior Manager, Compliance
Fremont, CA
Director, Office of Device Evaluation
FDA, Center for Devices and Radiological Health
Silver Spring, MD